The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
PRIMA-1 induces apoptosis by inhibiting JNK signaling but promoting the activation of Bax
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“PRIMA-1 restores the wild-type conformation and DNA contact of p53 mutants, and induces transcription of the downstream target genes BAX, P21 and PUMA.386–388”
From Targeting p53 pathways: mechanisms, structures, and advances in therapy (2023) · cites this paper as [387]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Restoration of the tumor suppressor function to mutant p53 by a low-molecular-weight compound
Bykov, V. J. N., Issaeva, N., Shilov, A., Hultcrantz, M., Pugacheva, E., Chumakov, P., Bergman, J., Wiman, K. G., & Selivanova, G. (2002) · Nature Medicine · doi:10.1038/nm0302-282 · Cited by 1,067
PRIMA-1MET synergizes with cisplatin to induce tumor cell apoptosis
Bykov, V. J. N., Zache, N., Stridh, H., Westman, J., Bergman, J., Selivanova, G., & Wiman, K. G. (2005) · Oncogene · doi:10.1038/sj.onc.1208419 · Cited by 252
Li, Y., Mao, Y., Brandt-Rauf, P. W., Williams, A. C., & Fine, R. L. (2005) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-04-0206 · Cited by 57
Research works printed but not linked: 27
- Vogelstein, 2000, Surfing the p53 network, Nature (Lond.), 408, 30710, 10.1038/35042675 · DOI · Paper page
- Colman, 2000, Regulation of p53 stability and activity in response to genotoxic stress, Mutat. Res., 462, 179, 10.1016/S1383-5742(00)00035-1 · DOI · Paper page
- Daoud, 2003, Impact of p53 knockout and topotecan treatment on gene expression profiles in human colon carcinoma cells: a pharmacogenomic study, Cancer Res., 63, 2782
- Lai, 2000, Mutations in the p53 tumor suppressor gene and early onset breast cancer, Cancer Biol. Ther., 1, 231
- Bull, 2004, The combination of p53 mutation and neu/erbB2 amplification is associated with poor survival in node-negative breast cancer, J. Clin. Oncol., 22, 86, 10.1200/JCO.2004.09.128 · DOI
- Selivanova, 1998, Reactivation of mutant p53: a new strategy for cancer therapy, Semin. Cancer Biol., 8, 369, 10.1006/scbi.1998.0099 · DOI
- Chipuk, 2003, Pharmacologic activation of p53 elicits Bax-dependent apoptosis in the absence of transcription, Cancer Cell, 4, 371, 10.1016/S1535-6108(03)00272-1 · DOI · Paper page
- Wang, 2006, PRIMA-1-induces apoptosis in p53 mutant breast cancer cell lines by inhibiting the JNK cell survival pathway and promoting the activation of proapoptotic p53 targets Bax and PUMA, Proc. AACR, 47, 2214
- Rehman, 2005, Proteomic identification of heat shock protein 90 as a candidate target for p53 mutation reactivation by PRIMA-1 in breast cancer cells, Breast Cancer Res., 7, R765, 10.1186/bcr1290 · DOI
- Miled, 2005, A genomic map of p53 binding sites identifies novel p53 targets involved in an apoptotic network, Cancer Res., 65, 5096, 10.1158/0008-5472.CAN-04-4232 · DOI
- Redkar, 2004, Implication of p53 in growth arrest and apoptosis induced by combined treatment with topotecan and UCN-01 in human mammary epithelial cells, J. Exp. Ther. Oncol., 4, 213
- Appella, 2000, Signaling of p53: breaking the posttranslational modification code, Pathol. Biol. (Paris), 48, 227
- Stewart, 2001, Increased p53 phosphorylation after microtubule disruption is mediated in a microtubule inhibitor- and cell specific manner, Oncogene, 20, 113, 10.1038/sj.onc.1204060 · DOI
- Bean, 2001, Phosphorylation of serines 15 and 37 is necessary for efficient accumulation of p53 following irradiation with UV, Oncogene, 20, 1076, 10.1038/sj.onc.1204204 · DOI
- Wang, 2003, Stabilization of p53 by CP-31398 inhibits ubiquitination without altering phosphorylation at serine 15 or 20 or MDM2 binding, Mol. Cell. Biol., 23, 2171, 10.1128/MCB.23.6.2171-2181.2003 · DOI · Paper page
- Unger, 1999, Mutations in serines 15 and 20 of human p53 impair its apoptotic activity, Oncogene, 18, 3205, 10.1038/sj.onc.1202656 · DOI · Paper page
- Wang, 2003, Phosphorylation and hsp90 binding mediate heat shock stabilization of p53, J. Biol. Chem., 278, 2066, 10.1074/jbc.M206697200 · DOI
- Kaeser, 2002, Chromatin immunoprecipitation analysis fails to support the latency model for regulation of p53 DNA binding activity in vivo, Proc. Natl. Acad. Sci. USA, 99, 95, 10.1073/pnas.012283399 · DOI · Paper page
- Yao, 1999, HGK that specifically activates the c-Jun-N-terminal kinase signaling pathway, J. Biol. Chem., 274, 2118, 10.1074/jbc.274.4.2118 · DOI · Paper page
- Weston, 2002, The JNK signal transduction pathway, Curr. Opin. Genet. Dev., 12, 14, 10.1016/S0959-437X(01)00258-1 · DOI · Paper page
- Lin, 2002, Activation of the JNK signaling pathway: breaking the brake on apoptosis, BioEssays, 25, 17, 10.1002/bies.10204 · DOI · Paper page
- Potapova, 2000, Inhibition of c-Jun N-terminal kinase-2 expression suppresses growth and induces apoptosis of human tumor cells in a p53-dependent manner, Mol. Cell. Biol., 20, 1713, 10.1128/MCB.20.5.1713-1722.2000 · DOI
- Shaulian, 2002, AP-1 as a regulator of cell life and death, Nat. Cell Biol., 4, E131, 10.1038/ncb0502-e131 · DOI · Paper page
- Liu, 2005, Role of JNK activation in apoptosis: a double-edged sword, Cell Res., 15, 36, 10.1038/sj.cr.7290262 · DOI · Paper page
- Lee, 2006, Expression proteomics to p53 mutation reactivation with PRIMA-1 in breast cancer cells, Biochem. Biophys. Res. Commun., 349, 1117, 10.1016/j.bbrc.2006.08.152 · DOI
- Li, 2006, Essential role of c-Jun-NH2-terminal kinase on synergy induction of apoptosis by TRAIL plus ADM in ADM resistant MCF-7/ADM cells, Apoptosis, 11, 1239, 10.1007/s10495-006-7494-8 · doi:10.1007/s10495-006-7494-8
- Hsu, 2006, Plumbagin (5-hydroxy-2-methyl-1,4-naphthoquinone) induces apoptosis and cell cycle arrest in A549 cells through p53 accumulation via c-Jun NH2-terminal kinase-mediated phosphorylation at serine 15 in vitro and in vivo, J. Pharmacol. Exp. Ther., 318, 484, 10.1124/jpet.105.098863 · DOI · Paper page
Cited by
Targeting p53 pathways: mechanisms, structures, and advances in therapy
Wang, H., Guo, M., Wei, H., & Chen, Y. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01347-1 · Cited by 1,016
Lehmann, S., Bykov, V. J. N., Ali, D., Andrén, O., Cherif, H., Tidefelt, U., Uggla, B., Yachnin, J., Juliusson, G., Moshfegh, A., et al. (2012) · Journal of Clinical Oncology · doi:10.1200/jco.2011.40.7783 · Cited by 406
Perdrix, A., Najem, A., Saussez, S., Awada, A., Journe, F., Ghanem, G., & Krayem, M. (2017) · Cancers · doi:10.3390/cancers9120172 · Cited by 126
Regulation of MDMX nuclear import and degradation by Chk2 and 14-3-3
LeBron, C., Chen, L., Gilkes, D. M., & Chen, J. (2006) · The EMBO Journal · doi:10.1038/sj.emboj.7601032 · Cited by 122
PRIMA-1MET inhibits growth of mouse tumors carrying mutant p53.
(2008) · PubMed Central · doi:10.3233/clo-2008-0440 · Cited by 68
Metadata
- Authors
- Wang, T., Lee, K., Rehman, A., & Daoud, S. S.
- Venue
- Biochemical and Biophysical Research Communications
- Publisher
- Elsevier BV
- Published
- 2007-01
- Volume
- 352
- Issue
- 1
- Pages
- 203-212
- ISSN
- 0006-291X
- Cited by
- 26
- References
- 3
- Language
- en
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.